These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 30320609)

  • 1. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
    Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
    Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
    Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor Survival After Retransplantation in NASH Cirrhosis.
    Thuluvath AJ; Chen PH; Thuluvath PJ; Kantsevoy S; Savva Y
    Transplantation; 2019 Jan; 103(1):101-108. PubMed ID: 29470354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
    Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future Trends in Demand for Liver Transplant: Birth Cohort Effects Among Patients With NASH and HCC.
    Shingina A; DeWitt PE; Dodge JL; Biggins SW; Gralla J; Sprague D; Bambha K
    Transplantation; 2019 Jan; 103(1):140-148. PubMed ID: 30451739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
    Younossi ZM
    Liver Transpl; 2018 Feb; 24(2):166-170. PubMed ID: 29272073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.
    Sadler EM; Mehta N; Bhat M; Ghanekar A; Greig PD; Grant DR; Yao F; Sapisochin G
    Transplantation; 2018 Apr; 102(4):640-647. PubMed ID: 29319620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
    Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
    World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
    Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
    J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
    Noureddin M; Vipani A; Bresee C; Todo T; Kim IK; Alkhouri N; Setiawan VW; Tran T; Ayoub WS; Lu SC; Klein AS; Sundaram V; Nissen NN
    Am J Gastroenterol; 2018 Nov; 113(11):1649-1659. PubMed ID: 29880964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
    Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis.
    Thuluvath PJ; Hanish S; Savva Y
    Transplantation; 2018 Apr; 102(4):656-663. PubMed ID: 29215462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
    Younossi ZM; Stepanova M; Ong J; Trimble G; AlQahtani S; Younossi I; Ahmed A; Racila A; Henry L
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):580-589.e5. PubMed ID: 32531342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
    Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
    Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies.
    Nagai S; Collins K; Chau LC; Safwan M; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2759-2768.e5. PubMed ID: 31004758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.